These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7222106)

  • 1. Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate.
    von Däniken A; Lutz WK; Schlatter C
    Toxicol Lett; 1981 Feb; 7(4-5):305-10. PubMed ID: 7222106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate.
    Barnard SD; Molello JA; Caldwell WJ; LeBeau JE
    J Toxicol Environ Health; 1980 May; 6(3):547-57. PubMed ID: 7420463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benfluorex and fenofibrate treatment on mitochondrial and peroxisomal marker enzymes in rat liver.
    Van Veldhoven P; Declercq PE; Debeer LJ; Mannaerts GP
    Biochem Pharmacol; 1984 Apr; 33(7):1153-5. PubMed ID: 6712725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate.
    Price SC; Hinton RH; Mitchell FE; Hall DE; Grasso P; Blane GF; Bridges JW
    Toxicology; 1986 Oct; 41(2):169-91. PubMed ID: 3764941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratological study of the hypolipidaemic drugs etofylline clofibrate (VULM) and fenofibrate in Swiss mice.
    Ujházy E; Onderová E; Horáková M; Bencová E; Durisová M; Nosál R; Balonová T; Zeljenková D
    Pharmacol Toxicol; 1989 Mar; 64(3):286-90. PubMed ID: 2726692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.
    Cayen MN; Ferdinandi ES; Greselin E; Robinson WT; Dvornik D
    J Pharmacol Exp Ther; 1977 Jan; 200(1):33-43. PubMed ID: 833760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    Cancer Lett; 1990 Aug; 53(1):33-8. PubMed ID: 2397479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?
    Liu HF; Vincent-Viry M; Galteau MM; Guéguen R; Magdalou J; Nicolas A; Leroy P; Siest G
    Eur J Clin Pharmacol; 1991; 41(2):153-9. PubMed ID: 1743248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human liver 3alpha-hydroxysteroid dehydrogenase by clofibrate derivatives.
    Matsuura K; Hara A; Kato M; Deyashiki Y; Miyabe Y; Ishikura S; Sugiyama T; Katagiri Y
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1096-103. PubMed ID: 9618412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of lipid normalizers (clofibrate and procetofene) on chylomicron metabolism in rats].
    Bourdeaux AM; Paris RM
    Arch Int Physiol Biochim; 1980 Feb; 88(1):75-84. PubMed ID: 6155886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Triglyceride synthesis and oleic acid catabolism by hepatic microsomes and mitochondria in clofibrate or procetofen-treated rats].
    Clouet E; Paris R
    Reprod Nutr Dev (1980); 1980; 20(3A):637-45. PubMed ID: 7349434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate.
    Kramer JA; Blomme EA; Bunch RT; Davila JC; Jackson CJ; Jones PF; Kolaja KL; Curtiss SW
    Toxicol Pathol; 2003; 31(4):417-31. PubMed ID: 12851107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
    Orton TC; Parker GL
    Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds.
    Lalwani ND; Fahl WE; Reddy JK
    Biochem Biophys Res Commun; 1983 Oct; 116(2):388-93. PubMed ID: 6651818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate and human liver. Lack of proliferation of peroxisomes.
    Gariot P; Barrat E; Mejean L; Pointel JP; Drouin P; Debry G
    Arch Toxicol; 1983 Jun; 53(2):151-63. PubMed ID: 6882216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vivo genotoxic potential of fenofibrate in rats subjected to two-week repeated oral administration.
    Tawfeeq MM; Suzuki T; Shimamoto K; Hayashi H; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Aug; 85(8):1003-11. PubMed ID: 21127841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of sister chromatid exchanges by the peroxisome proliferators 2,4-D, MCPA, and clofibrate in vivo and in vitro.
    Linnainmaa K
    Carcinogenesis; 1984 Jun; 5(6):703-7. PubMed ID: 6722984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the involvement of selenium in peroxisome proliferation in rat liver. Comparison of effects with clofibric acid and perfluorooctanoic acid and the pharmacokinetics of [14C]clofibrate.
    Olsson U; Sundberg C; Andersson K; De Pierre JW
    Biochem Pharmacol; 1993 Nov; 46(10):1805-10. PubMed ID: 8250967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.
    Seifert J; Mostecká H
    Carcinogenesis; 1988 Jan; 9(1):3-8. PubMed ID: 2446797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.